Page last updated: 2024-10-26

dichlorphenamide and Brucellosis

dichlorphenamide has been researched along with Brucellosis in 1 studies

Dichlorphenamide: A carbonic anhydrase inhibitor that is used in the treatment of glaucoma.
diclofenamide : A sulfonamide that is benzene-1,3-disulfonamide in which the hydrogens at positions 4 and 5 are substituted by chlorine. An oral carbonic anhydrase inhibitor, it partially suppresses the secretion (inflow) of aqueous humor in the eye and so reduces intraocular pressure. It is used for the treatment of glaucoma.

Brucellosis: Infection caused by bacteria of the genus BRUCELLA mainly involving the MONONUCLEAR PHAGOCYTE SYSTEM. This condition is characterized by fever, weakness, malaise, and weight loss.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Joseph, P1
Turtaut, F1
Ouahrani-Bettache, S1
Montero, JL1
Nishimori, I1
Minakuchi, T1
Vullo, D1
Scozzafava, A1
Köhler, S1
Winum, JY1
Supuran, CT1

Other Studies

1 other study available for dichlorphenamide and Brucellosis

ArticleYear
Cloning, characterization, and inhibition studies of a beta-carbonic anhydrase from Brucella suis.
    Journal of medicinal chemistry, 2010, Mar-11, Volume: 53, Issue:5

    Topics: Amino Acid Sequence; Animals; Base Sequence; Brucella suis; Brucellosis; Carbonic Anhydrases; Clonin

2010